| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 915-926, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
R Pichler, CM Giachelli, D Lombardi, J Pippin, K Gordon, CE Alpers, SM Schwartz and RJ Johnson
Division of Nephrology, University of Washington Medical Center, Seattle 98195.
Interstitial inflammation and tubular injury accompany most types of glomerulonephritis and are likely to mediate progressive renal injury. We hypothesized that the interstitial monocyte/macrophage accumulation in nephritis involves osteopontin, a cell attachment glycoprotein that avidly binds macrophages in vitro and induces a macrophage-rich infiltrate on subcutaneous injection in mice (Singh et al, J Exp Med, 1990, 171: 1931). In this study, we demonstrate that osteopontin messenger RNA and protein levels are up-regulated in a proportion of proximal and distal tubules in three experimental models of glomerulonephritis. In all three models, the expression of osteopontin initially precedes histological evidence of tubular injury, but is correlated with subsequent sites of monocyte/macrophage accumulation and tubular damage. Osteopontin expression also correlates with the severity of the tubulointerstitial injury, being greatest in amino- nucleoside nephrosis. These data suggest that 1) osteopontin is up- regulated in tubules in glomerular disease; 2) osteopontin may be important for macrophage accumulation at specific sites in diseased tissue; and 3) osteopontin may therefore have a role in the pathogenesis of the tubulointerstitial injury that accompanies glomerulonephritis.
This article has been cited by other articles:
 |
|
 |
|
  T. Nakagawa, I. Tashiro, M. Fujimoto, M. Jo, S. Sakai, H. Oka, H. Goto, Y. Shimada, and N. Shibahara Keishibukuryogan Reduces Renal Injury in the Early Stage of Renal Failure in the Remnant Kidney Model Evid. Based Complement. Altern. Med., July 24, 2009; (2009) nep089v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. E. Choi, S. K. Ahn, W. T. Lee, J. E. Lee, S. H. Park, B. B. Yoon, and K. A. Park Soybeans Ameliolate Diabetic Nephropathy in Rats Evid. Based Complement. Altern. Med., March 20, 2008; (2008) nen021v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sahai, P. Malladi, X. Pan, R. Paul, H. Melin-Aldana, R. M. Green, and P. F. Whitington Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1035 - G1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sahai, P. Malladi, H. Melin-Aldana, R. M. Green, and P. F. Whitington Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G264 - G273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ding, M. Zhao, W. Zou, Y. Liu, and H. Wang Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study Lupus, February 1, 2004; 13(2): 113 - 118. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Hirata, S. Masuda, T. Tamura, K. Kai, K. Ojima, A. Fukase, K. Motoyoshi, K. Kamakura, Y. Miyagoe-Suzuki, and S.'i. Takeda Expression Profiling of Cytokines and Related Genes in Regenerating Skeletal Muscle after Cardiotoxin Injection: A Role for Osteopontin Am. J. Pathol., July 1, 2003; 163(1): 203 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nangaku, J. Pippin, and W. G. Couser C6 Mediates Chronic Progression of Tubulointerstitial Damage in Rats with Remnant Kidneys J. Am. Soc. Nephrol., April 1, 2002; 13(4): 928 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes Osteopontin--a molecule for all seasons QJM, January 1, 2002; 95(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagasawa, M. Takenaka, J. Kaimori, Y. Matsuoka, Y. Akagi, M. Tsujie, E. Imai, and M. Hori Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis Nephrol. Dial. Transplant., May 1, 2001; 16(5): 923 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Verstrepen, V. P. Persy, A. Verhulst, S. Dauwe, and M. E. De Broe Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat Nephrol. Dial. Transplant., April 1, 2001; 16(4): 712 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Takahashi, K. Takahashi, T. Okazaki, K. Maeda, H. Ienaga, M. Maeda, S. Kon, T. Uede, and Y. Fukuchi Role of Osteopontin in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 264 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. SATOH, N. KASHIHARA, Y. YAMASAKI, K. MARUYAMA, K. OKAMOTO, Y. MAESHIMA, H. SUGIYAMA, T. SUGAYA, K. MURAKAMI, and H. MAKINO Renal Interstitial Fibrosis Is Reduced in Angiotensin II Type 1a Receptor-Deficient Mice J. Am. Soc. Nephrol., February 1, 2001; 12(2): 317 - 325. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. BONVINI, U. SCHATZMANN, B. BECK-SCHIMMER, L. K. SUN, S. R. RITTLING, D. T. DENHARDT, M. LE HIR, and R. P. WÜTHRICH Lack of In Vivo Function of Osteopontin in Experimental Anti-GBM Nephritis J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1647 - 1655. [Abstract] [Full Text]
|
|
|
|
|
|
H. Okada, K. Moriwaki, R. Kalluri, T. Takenaka, H. Imai, S. Ban, M. Takahama, and H. Suzuki Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats Am J Physiol Renal Physiol, January 1, 2000; 278(1): F110 - F121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. NANGAKU, J. PIPPIN, and W. G. COUSER Complement Membrane Attack Complex (C5b-9) Mediates Interstitial Disease in Experimental Nephrotic Syndrome J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2323 - 2331. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. J. Johnson, K. L. Gordon, S. Suga, A. M. Duijvestijn, K. Griffin, and A. Bidani Renal Injury and Salt-Sensitive Hypertension After Exposure to Catecholamines Hypertension, July 1, 1999; 34(1): 151 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. HUDKINS, C. M. GIACHELLI, YAN CUI, W. G. COUSER, R. J. JOHNSON, and C. E. ALPERS Osteopontin Expression in Fetal and Mature Human Kidney J. Am. Soc. Nephrol., March 1, 1999; 10(3): 444 - 457. [Abstract] [Full Text]
|
|
|
|
|
|
X. Q. Yu, J.-M. Fan, D. J. Nikolic-Paterson, N. Yang, W. Mu, R. Pichler, R. J. Johnson, R. C. Atkins, and H. Y. Lan IL-1 Up-Regulates Osteopontin Expression in Experimental Crescentic Glomerulonephritis in the Rat Am. J. Pathol., March 1, 1999; 154(3): 833 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Remuzzi and T. Bertani Pathophysiology of Progressive Nephropathies N. Engl. J. Med., November 12, 1998; 339(20): 1448 - 1456. [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, C. Louden, T.-L. Yue, J. A. Ellison, F. C. Barone, H. A. Solleveld, and G. Z. Feuerstein Delayed Expression of Osteopontin after Focal Stroke in the Rat J. Neurosci., March 15, 1998; 18(6): 2075 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bayless, G. Meininger, J. Scholtz, and G. Davis Osteopontin is a ligand for the alpha4beta1 integrin J. Cell Sci., January 5, 1998; 111(9): 1165 - 1174. [Abstract] [PDF]
|
|
|
|
 |
|
 Qu-Hong, L. F. Brown, H. F. Dvorak, and A. M. Dvorak Ultrastructural Immunogold Localization of Osteopontin in Human Gastric Mucosa J. Histochem. Cytochem., January 1, 1997; 45(1): 21 - 34. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
